The Journal of Medical Ethics recently published the results of an Australian survey involving 96 physicians from 10 medical specialties who were asked why patients at the end of life are often prescribed treatments that [more]
Health journalists from all over Europe are invited to apply for one of the 12 fellowships to attend the European Cancer Congress ECCO2017, which will be held in Amsterdam from 27-30 January 2017, with the [more]
Any educational effort in the rare cancer area makes little sense if disconnected from a networking environment.Thus, this Course will be first offered to clinical oncologists involved into the existing networks covering rare adult solid [more]
The next ESMO Preceptorship courses on Immuno-oncology – that offer an enriched learning experience, thanks to their small size and emphasis on interaction with fellow participants and faculty – will be held in Amsterdam (The [more]
“In the history of cancer research, there has always been tension between those who want to treat cancer and those who think we should prevent it,” writes the pioneering medical oncologist and former head of the [more]
Molecular imaging specialists are ready to break out of their research huddles and take their place at the heart of clinical decision making. But can they convince clinicians to welcome them in? Anna Wagstaff investigates. [more]
Her campaign to bring a human touch to healthcare, which she carries on even through the tough final stages of cancer, has had widespread impact and brought international acclaim. Simon Crompton talked to the woman [more]
Eurocare, the landmark series of studies comparing survival of cancer patients among European countries, has been profoundly important in focusing attention on the quality of Europe’s cancer services over the past two decades. Now in [more]
Mr Lloyd is angry! His elderly mother is getting no treatment for her metastatic lung cancer, and he doesn’t want to hear what the doctors and nurses are saying… …A different approach by a new [more]
Cancer is not the first thing that springs to mind when one thinks about conflict and refugees, but bear with me and I will explain why this is such a problem now. Back in the [more]
Acute skin reactions associated with radiotherapy can be distressing and can lead to treatment interruption. Anticipating, assessing and managing the problem according to best evidence can make a big difference. Radiotherapy-related toxicity occurs because of [more]
Progress in understanding resistance and learning how to combine and sequence therapies most effectively is being stifled because specimens donated by patients, and related data, are being hoarded and not shared. Peter McIntyre reports. There [more]
Repurposing established drugs for oncology patients offers the potential to deliver cheaper and faster drug development. This could help close the widening gap between patient expectations and healthcare budgets, as the cost of medical anticancer [more]